ForSight VISION5 is focused on developing non-invasive products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5’s lead product candidate is the Helios(TM) insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication.
View Top Employees from ForSight VISION5 (now Allergan)| Website | http://forsightvision5.com/ |
| Employees | 7 (7 on RocketReach) |
| Founded | 2010 |
| Phone | (650) 325-2050 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Incubators, Financial Services, Lending and Investments, Medical, Health Care, Pharmaceutical |
Looking for a particular ForSight VISION5 (now Allergan) employee's phone or email?
ForSight VISION5 (now Allergan) Questions
Ayman Naseri is the President and Chief Medical Officer of ForSight VISION5 (now Allergan).
7 people are employed at ForSight VISION5 (now Allergan).
Top ForSight VISION5 (now Allergan) Employees
-
View
Ayman Naseri
President and Chief Medical Officer at ForSight VISION5 (now Allergan)
South San Francisco, CA, US12 -
22
-
2
Related Companies
